The health insurance extends its coverage to the Hoya MiYosmart glass

The constant evolution of optical technologies in the field of visual health marks an important milestone with the extended coverage by Health Insurance of the Hoya MiYosmart lens. This innovation in the treatment of childhood myopia is now set within a context of reinforced prevention in response to the concerning increase in cases of progressive myopia among children. In 2025, specific coverage by Social Security and supplementary health insurance positions this lens as a key lever to reduce the development of high myopia, a major public health issue. It is no longer just about correcting vision but also about directly acting on the progression of myopia, which significantly changes the dynamics of visual prevention. The adoption of an LPP (List of Products and Services) code under the brand name MiYosmart officially recognizes this innovative technology, facilitating access for affected children aged 5 to 16, and contributing to better overall visual protection.

The decision to include this type of lens in the list of equipment benefiting from specific reimbursement is the result of three years of intense negotiations between the manufacturer Hoya, government institutions, complementary organizations (Ocam), and optical professionals. This process aims to address a dual challenge: limiting the health consequences associated with the rapid progression of myopia and facilitating economic access to these dual-function corrective and slowing lenses. The collective awareness of the risks linked to high myopia, including the increased risk of severe ocular complications in adulthood, played a decisive role in the adoption of this measure.

The specific coverage provided by Health Insurance amounts to €44.28 on a total cost of €147.60 per lens, reflecting an effort to reduce the out-of-pocket costs for families, which will be supplemented by responsible mutual insurance contracts. Social Security thus follows an efficiency-driven health dynamic by supporting an innovative solution recognized and validated by the Haute Autorité de Santé (HAS). This advancement also marks a turning point in the use of lenses in optics, emphasizing eligibility criteria focused on at-risk profiles—children with high myopia or rapid progression, with rigorous monitoring and appropriate renewal.

Innovative features of the Hoya MiYosmart lens for slowing progressive myopia

The MiYosmart lens from Hoya introduces an innovative concept in childhood optics, combining visual correction with action to slow myopia progression. This technical and functional specificity distinguishes this product from traditional single-focus lenses. Its design is based on a patented technology called D.I.M.S. (Defocus Incorporated Multiple Segments), enabling the creation of a specific focal shift capable of stimulating the retina to slow down the exaggerated growth of the eye, the primary cause of progressive myopia.

• 🛡️ Dual function : correction of myopia and slowing its evolution.
• 🔬 D.I.M.S. technology : integrated multiple segments to induce controlled focal shift.
• 👁️ Designed specifically : tailored for children aged 5 to 16 at risk of rapid progression.
• ⚙️ Patented optical structure : validated by clinical studies showing a reduction in myopia progression between 30% and 60%.

This innovative structure represents a significant breakthrough in the field of pediatric visual protection. By effectively slowing myopia, it plays a crucial role in preventing potential complications such as retinal detachment or macular degeneration, which are often associated with high myopia in adulthood. The MiYosmart lens, combining correction and prevention, thus offers meaningful health benefits.

🔑 Characteristic	⚙️ Description	📊 Clinical Impact
Dual function	Optical correction + myopia slowing	Reduces progression by 30%-60%
D.I.M.S. technology	Multiple segments creating focal shift	Stimulates the retina to slow eye growth
Target audience	Children aged 5 to 16 at risk of progression	Optimal management according to HAS criteria
Validation	Clinical studies and official recognition	Approval from Health Insurance and supplementary insurers

This innovative framework constitutes a real advance in the field of pediatric visual protection. By effectively slowing myopia, it plays a key role in preventing potential complications like retinal detachment or macular degeneration, often associated with high myopia in adulthood. The MiYosmart lens, combining correction and prevention, thus offers significant health value.

It should be noted that this technical innovation also involves an evolution in the role of healthcare professionals in monitoring and prescribing, leading to regular control of the myopic progression of patients to adapt the renewal of equipment optimally.

Coverage by the Health Insurance: Modalities and Challenges for Families

The specific reimbursement of the Hoya MiYosmart lens by Health Insurance represents a significant advance in access to myopia slowing solutions. From now on, Health Insurance covers up to €44.28 of a recommended retail price of €147.60 including tax per lens. This coverage results in a tangible reduction of the remaining costs for families, which can be further supplemented by coverage through their supplementary health plans, provided they have a responsible contract.

Among the conditions to benefit from this reimbursement, several criteria are essential:

• 📋 Mandatory prescription of the MiYosmart lens mentioning the LPP code 2236215 on the prescription.
• 👶 Child’s age between 5 and 16 years.
• 📈 Confirmation of high myopia (≥ -6 diopters) or rapid progression (≥ -0.5 diopters per year) according to thresholds established by HAS.
• 🔄 First equipment or renewal for the profile concerned.

It should be noted that this coverage is strictly reserved for cases meeting the most severe clinical thresholds to optimize the use of public health resources. For other patients, especially those not meeting HAS criteria, an alternative management is available via a separate EDI exchange code, allowing access to the MiYosmart Open range. This measure aims to prevent the exclusion of myopic children who still require suitable visual correction while benefiting from Hoya’s technology.

🔖 Criterion	✅ Condition	💡 Objective
Age	Between 5 and 16 years	Target population for effective slowing
High myopia	≥ -6 diopters	High-risk patient
Rapid myopia progression	≥ -0.5 diopters/year	Urgent monitoring and management
LPP Code	2236215 on prescription	Ensures specific coverage

This organization also facilitates coordination among ophthalmologists, orthoptists, and opticians, establishing a specialized eyewear referral pathway for targeted management. The goal is to achieve maximum visual protection through appropriate monitoring, combining innovative technologies and responsible reimbursement policies.

The Health Impact of MiYosmart Lens Coverage on the Prevention of High Myopia

High or progressive myopia presents a major challenge for ocular health both nationally and globally. It is associated with an increased risk of serious eye diseases such as glaucoma, cataracts, or retinal detachment, which can lead to permanent vision loss. In this context, the reimbursement measure for the Hoya MiYosmart lens represents a determined action to limit these risks by intervening early in the course of childhood myopia.

Clinical data validated by the Haute Autorité de Santé and ophthalmology expert societies indicate a significant slowdown in myopia progression among children equipped with the MiYosmart lens. The average reduction observed ranges from 30% to 60%, representing a crucial gain not only in immediate quality of life but also in preventing subsequent pathologies.

• 🩺 Risk reduction : decrease in incidence of complications related to high myopia.
• 👦👧 Target population : children aged 5 to 16 at high risk.
• 🔄 Regular monitoring : renewing prescriptions according to myopia progression.
• 💸 Economic optimization : early prevention leading to savings on costly future treatments.

📈 Indicator	📉 Expected Effect	💰 Impact on Costs
Myopia progression	Decrease by 30% to 60%	Reduction in future surgical needs
Incidence of complications	Significant reduction	Lower expenses related to serious pathologies
Quality of life	Notable improvement for young patients	Fewer major medical interventions

This policy aims to exemplify comprehensive visual protection and integrated prevention, positioning the MiYosmart lens as a key actor in the public health optical strategy.

The Integration of the MiYosmart Lens into Reimbursement Policy: Role of Supplementary Insurers

Beyond the participation of the Health Insurance, supplementary health insurers play a crucial role in covering the full cost of Hoya MiYosmart lenses. These contracts, often called “responsible,” cover the remaining share that can exceed €100 per lens, significantly reducing the out-of-pocket expenses.

This coordinated approach seeks to :

• 💼 Ensure equitable access to innovative technologies among families, regardless of income.
• 🏥 Promote a preventive optical health policy, reinforcing actions initiated by Social Security.
• ⚖️ Avoid exceeding budgets, by providing a secure financial framework for consumers.
• 🔗 Facilitate coordination among care providers and optical health coverage actors.

🎯 Objective	📌 Description	🤝 Key Partner
Accessibility	Supplementary coverage of out-of-pocket costs	Mutual insurance and supplementary coverage providers
Prevention	Strengthening myopia prevention actions	Responsible contracts
Financial balance	Reducing budget overruns related to lens costs	Healthcare professionals and insurers
Coordination	Medical follow-up and integrated coverage	Ophthalmologists, opticians, insurers

This organization also emphasizes that coverage by supplementary insurers is contingent upon membership in a responsible contract, highlighting the importance of informed choices by families to ensure optimal coverage. This model ensures an effective eyewear pathway in the fight against progressive myopia, strengthening efforts in visual health.

Impact on the Optical Market and the Vision Care Sector

The official recognition of partial reimbursement for the MiYosmart lens deeply transforms market dynamics. The manufacturer Hoya benefits from strong institutional recognition, enabling it to assert its position in the innovative and therapeutic segment of eyeglass lenses, which was previously underappreciated in the nomenclature. This lens becomes an iconic product, marking the shift toward more preventive and personalized optics.

This change has notable repercussions:

• 📊 Market stimulation through the novelty and increased coverage.
• 🏭 Strategic directions for lens manufacturers toward similar innovations.
• 🛠️ Enhanced offerings at points of sale and optical laboratories.
• 📈 Expected growth in equipment incorporating corrective slowing lenses.

🛒 Element	📈 Observed effect	🏆 Direct consequence
Official recognition	Specific reimbursement by Health Insurance	Increased demand
Technological innovation	Enhancement of R&D	Development of similar products
Optical sales points	Enriched and specialized offers	Better customer coverage
Market for equipment	Growth of the myopia slowing segment	Consolidation of the vision health sector

This evolution also contributes to raising awareness of issues related to childhood visual health, further informing families and health professionals about the importance of adopting suitable solutions from an early age.

Education and Awareness Around Progressive Myopia and Visual Protection

The significant increase in myopia among children underscores the urgency of a collective awareness. The inclusion of the MiYosmart lens in the reimbursement system necessarily comes with an active policy of information and education targeting families and optical health professionals.

Awareness campaigns emphasize several key aspects :

• 📚 Clear information : about the risks of high myopia and the benefits of slowing lenses.
• 🔍 Early diagnosis : importance of regular assessments by specialists.
• 👓 Support for choices : role of opticians and ophthalmologists in recommending appropriate correction.
• 🧒 Family support : guidance and advice to ensure regular wear.

This educational effort aims to create an effective eyewear framework not only technically but also behaviorally, facilitating the sustainable adoption of Hoya MiYosmart solutions in the fight against childhood myopia progression.

🎓 Educational Objective	📌 Recommended Action	📅 Timeline
Family information	Educational materials and media campaigns	Ongoing throughout the year
Diagnosis	Minimum annual visual assessment	Each year during consultations
Guidance	Targeted MiYosmart prescriptions	Based on myopia progression
Behavioral follow-up	Advice to parents/guardians	After each renewal

Future Perspectives for Optical Coverage and Innovations by 2030

The current decision to expand the coverage of Health Insurance to include the MiYosmart lens paves the way for a profound change in optical health practices. By 2030, several technological and organizational challenges are expected :

• 🔮 Development of new technologies aimed at preventing and correcting evolving ametropias.
• 🤖 Integration of connected devices for real-time monitoring of myopia progression.
• 📊 Optimization of care pathways through better coordination between healthcare professionals and insurers.
• 🌍 Increased accessibility for all populations, including in less-covered areas.

The experience gained with Hoya MiYosmart will serve as a foundation for this movement of innovations and corrective measures. It demonstrates the impact of an integrated and exemplary health action that combines technological advances with appropriate reimbursement policies.

🚀 Field	📈 Expected Progress	🌟 Projected Benefits
Optical technologies	Advanced multifunctional lenses	Improved correction and prevention
Connected devices	Real-time personalized monitoring	Early and adjusted intervention
Care pathways	Enhanced coordination	Efficiency and better quality
Accessibility	Geographical coverage expansion	Guaranteed equality of access

Answers to Common Questions About the Coverage of the Hoya MiYosmart Lens

Q1: What is the specific regulation enabling reimbursement for the MiYosmart lens?
A: An order published in the Official Journal assigns a brand name LPP code (2236215) to the MiYosmart lens, ensuring specific coverage by the Health Insurance, separate from standard single-focus lenses.

Q2: What age group is covered by the MiYosmart lens?
A: This coverage targets children aged 5 to 16 years who have high myopia or rapid progression, according to thresholds set by HAS.

Q3: How is the cost of the equipment divided between the Health Insurance and supplementary insurers?
A: The Health Insurance reimburses €44.28 per lens on a total cost of €147.60 including tax. The remaining amount is covered, depending on the responsible contract, by the mutual insurer or the beneficiary’s health insurance.

Q4: Is there possible coverage for children not meeting HAS criteria?
A: Yes, through the MiYosmart Open system under a separate EDI code, coverage is available for approximately 1.6 million children who do not meet the priority criteria.

Q5: What is the expected impact of this reimbursement on visual health?
A: It is a real health lever to slow myopia progression, reduce cases of high myopia, and prevent severe complications, thereby contributing to better quality of life in the long term.

For more details, it is recommended to consult specialized sources such as Sante Magazine, La Croix, or Hoya Vision Care to follow recent developments in this coverage.

Source: www.frequenceoptic.fr